Investigations towards an efficacious and safe strangles vaccine:: submucosal vaccination with a live attenuated Streptococcus equi

被引:49
作者
Jacobs, AAC
Goovaerts, D
Nuijten, PJM
Theelen, RPH
Hartford, OM
机构
[1] Intervet Int BV, Bacteriol Res Dept, NL-5830 AA Boxmeer, Netherlands
[2] Univ Dublin Trinity Coll, Moyne Inst Prevent Med, Dept Microbiol, Dublin 2, Ireland
关键词
D O I
10.1136/vr.147.20.563
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
As part of a search for a safe and efficacious strangles vaccine, several different vaccines and different vaccination routes were tested in foals. The degree of protection was evaluated after an intranasal challenge with virulent Streptococcus egui by clinical, postmortem and bacteriological examinations. Inactivated vaccines containing either native purified M-protein (500 mug per dose) or whole S equi cells (10(10) cells per dose) administered at least twice intramuscularly at intervals of four weeks, did not protect against challenge. Different live attenuated S equi mutants administered at least twice at intervals of four weeks by the intranasal route were either safe but not protective or caused strangles. In contrast, a live attenuated deletion mutant administered intramuscularly, induced complete protection but also induced unacceptable local reactions at the site of vaccination Submucosal vaccination in the inner side of the upper lip with the live attenuated mutant at greater than or equal to 10(8) colony-forming units per dose, appeared to be safe and efficacious in foals as young as four months of age. The submucosal vaccinations caused small transient swellings that resolved completely within two weeks, and postmortem no vaccine remnants or other abnormalities were found at the site of vaccination.
引用
收藏
页码:563 / 567
页数:5
相关论文
共 16 条
[1]   CHARACTERIZATION OF THE ANTIPHAGOCYTIC ACTIVITY OF EQUINE FIBRINOGEN FOR STREPTOCOCCUS-EQUI SUBSP EQUI [J].
BOSCHWITZ, JS ;
TIMONEY, JF .
MICROBIAL PATHOGENESIS, 1994, 17 (02) :121-129
[2]  
GALAN J E, 1988, P34
[3]   PASSIVE TRANSFER OF MUCOSAL ANTIBODY TO STREPTOCOCCUS-EQUI IN THE FOAL [J].
GALAN, JE ;
TIMONEY, JF ;
LENGEMANN, FW .
INFECTION AND IMMUNITY, 1986, 54 (01) :202-206
[4]   MUCOSAL NASOPHARYNGEAL IMMUNE-RESPONSES OF HORSES TO PROTEIN ANTIGENS OF STREPTOCOCCUS-EQUI [J].
GALAN, JE ;
TIMONEY, JF .
INFECTION AND IMMUNITY, 1985, 47 (03) :623-628
[5]  
GALAN JE, 1987, INFECT IMMUN, V55, P3181
[6]  
GALAN JE, 1988, J CLIN MICROBIOL, V26, P1142
[7]   STRANGLES IN HORSE STUDS - INCIDENCE, RISK-FACTORS AND EFFECT OF VACCINATION [J].
JORM, LR .
AUSTRALIAN VETERINARY JOURNAL, 1990, 67 (12) :436-439
[8]   GENETIC-STRUCTURE OF POPULATIONS OF BETA-HEMOLYTIC LANCEFIELD GROUP-C STREPTOCOCCI FROM HORSES AND THEIR ASSOCIATION WITH DISEASE [J].
JORM, LR ;
LOVE, DN ;
BAILEY, GD ;
MCKAY, GM ;
BRISCOE, DA .
RESEARCH IN VETERINARY SCIENCE, 1994, 57 (03) :292-299
[9]   Affinity purification and characterization of a fibrinogen-binding protein complex which protects mice against lethal challenge with Streptococcus equi subsp. equi [J].
Meehan, M ;
Nowlan, P ;
Owen, P .
MICROBIOLOGY-UK, 1998, 144 :993-1003
[10]  
SRIVASTAVA SK, 1985, CAN J COMP MED, V49, P351